EEF1A2 and cancer: Recently, a novel STn-dependent mechanism for chemotherapeutic resistance of gastric cancer cells to cisplatin has been described, in which STn protects cancer cells against chemotherapeutic-induced cell death by decreasing the interaction of cell surface glycan receptors with galectin-3 and increasing its intracellular accumulation [73].